CD8A and neoplasm: Consequently, this combination activates more CD8+ T cells and suppresses tumor growth in vivo.[78] More extensive clinical trials are necessary to gain a deeper understanding of the precise functions of these drugs and to evaluate the synergistic effects of different therapies.